Make money doing the work you believe in

At this point Danaher and Thermo Fisher shouldn't be viewed as a duopoly (probably never should've). They have developed in different directions and always were in oligopoly markets with some over lap. Very diversified conglomerates with active M&A, compared to more comparable duopolies like the rest mentioned.

The Duopoly Portfolio

– S&P Global and Moody's $SPGI $MCO

– Visa and Mastercard $V $MA

– Eli Lilly and Novo Nordisk $LLY $NVO

May 10
at
8:07 AM
Relevant people

Log in or sign up

Join the most interesting and insightful discussions.